{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:18:47Z","timestamp":1790965127293,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023\/1912"],"award-info":[{"award-number":["IIRP-2023\/1912"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016281","name":"Sharda University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bmc.2025.118276","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T11:06:31Z","timestamp":1749294391000},"page":"118276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Targeting MAP kinase for inhibiting Leishmania promastigotes and amastigotes stages by L-alanine derived molecules and their anticancer potential against PANC-1 cancer cell lines"],"prefix":"10.1016","volume":"128","author":[{"given":"Misbah","family":"Shahid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Nharwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleema","family":"Fayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashika","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza Adil","family":"Beg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6273-3080","authenticated-orcid":false,"given":"Preeti","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Chouhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angamuthu","family":"Selvapandiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118276_b0005","series-title":"Neglected tropical diseases-sub-Saharan Africa","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-031-53901-5_5","article-title":"Leishmaniasis in sub-Saharan Africa","author":"Hailu","year":"2024"},{"key":"10.1016\/j.bmc.2025.118276_b0010","first-page":"72","article-title":"Community conversations: a tool in improving health outcomes and reducing the burden of visceral leishmaniasis (kala-azar) in Isiolo County, Kenya","volume":"6","author":"Marangu","year":"2024","journal-title":"European J Med Health Sci"},{"key":"10.1016\/j.bmc.2025.118276_b0015","series-title":"The diagnosis and treatment of protozoan diseases","author":"Bhatt","year":"2024"},{"key":"10.1016\/j.bmc.2025.118276_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fitd.2022.837460","article-title":"Tackling drug resistance and other causes of treatment failure in leishmaniasis","volume":"3","author":"Wijnant","year":"2022","journal-title":"Front Trop Dis"},{"key":"10.1016\/j.bmc.2025.118276_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-52774-6","article-title":"Biochemical characterization and chemical validation of Leishmania MAP Kinase-3 as a potential drug target","volume":"9","author":"Raj","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2025.118276_b0030","first-page":"1","article-title":"Chemokines signature and T cell dynamics in leishmaniasis: Molecular insight and therapeutic application","author":"Upadhyay","year":"2024","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.bmc.2025.118276_b0035","article-title":"Advancing treatment for leishmaniasis: from overcoming challenges to embracing therapeutic innovations","author":"Singh","year":"2024","journal-title":"ACS Infectious Diseases"},{"key":"10.1016\/j.bmc.2025.118276_b0040","first-page":"1","article-title":"Compressive stresses in cancer: characterization and implications for tumour progression and treatment","author":"Linke","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2025.118276_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012765","article-title":"Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB\/c mice","volume":"19","author":"Saberi","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2025.118276_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2023.116629","article-title":"Synthesis, DFT study, molecular docking and larvicidal activity of chitin inhibitor alanine derived compounds","volume":"245","author":"Shahid","year":"2023","journal-title":"Polyhedron"},{"key":"10.1016\/j.bmc.2025.118276_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122844","article-title":"Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases","author":"Bhattacharjee","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2025.118276_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103916","article-title":"An empirical review on the resistance mechanisms of epidermal growth factor receptor inhibitors and predictive molecular biomarkers in colorectal cancer","volume":"183","author":"Bhattacharya","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bmc.2025.118276_b0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41571-021-00558-1","article-title":"EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment","volume":"19","author":"Friedlaender","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bmc.2025.118276_b0070","doi-asserted-by":"crossref","DOI":"10.1039\/D4NJ03401E","article-title":"Synthesis, characterization, crystal structure, and molecular docking of o-vanillin and l-valine derived molecules: a DFT study and antiproliferative activity against the PANC-1 cancer cell line","author":"Shahid","year":"2025","journal-title":"New J Chem"},{"key":"10.1016\/j.bmc.2025.118276_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202202884","article-title":"DFT investigation, hirshfield analysis and molecular docking of cu (II) complex of O\u2010vanillin based ligand","volume":"7","author":"De","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmc.2025.118276_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290297","article-title":"Evaluation of farnesol orally and topically against experimental cutaneous leishmaniasis: in-vivo analysis","volume":"18","author":"Sharma","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2025.118276_b0085","article-title":"Advancing treatment for leishmaniasis: from overcoming challenges to embracing therapeutic innovations","author":"Singh","year":"2024","journal-title":"ACS Infectious Diseases"},{"key":"10.1016\/j.bmc.2025.118276_b0090","doi-asserted-by":"crossref","first-page":"e1671","DOI":"10.1371\/journal.pntd.0001671","article-title":"An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages","volume":"6","author":"Siqueira-Neto","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2025.118276_b0095","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2147\/DDDT.S244903","article-title":"Leishmania donovani growth inhibitors from pathogen box compounds of medicine for malaria venture","author":"Tadele","year":"2020","journal-title":"Drug Design, Dev Therapy"},{"key":"10.1016\/j.bmc.2025.118276_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107338","article-title":"Repurposing FDA approved drugs against sterol C-24 methyltransferase of Leishmania donovani: a dual in silico and in vitro approach","volume":"258","author":"Kumari","year":"2024","journal-title":"Acta Trop"},{"key":"10.1016\/j.bmc.2025.118276_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.126901","article-title":"Synthesis, characterization, molecular docking and DNA cleavage study of transition metal complexes of o-vanillin and glycine derived schiff base ligand","volume":"1199","author":"De","year":"2020","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2025.118276_b0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2025.118276_b0115","article-title":"Nanoliposomal miltefosine for the treatment of cutaneous leishmaniasis caused by Leishmania major (MRHO\/IR\/75\/ER): the drug preparation and in vitro study","volume":"5","author":"Najafian","year":"2016","journal-title":"Int J Pharm Res Allied Sci"},{"key":"10.1016\/j.bmc.2025.118276_b0120","doi-asserted-by":"crossref","first-page":"e1253","DOI":"10.1371\/journal.pntd.0001253","article-title":"A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit","volume":"5","author":"De Muylder","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2025.118276_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900262","article-title":"3\u2032\u2010(4\u2010(Benzyloxy) phenyl)\u20101\u2032\u2010phenyl\u20105\u2010(heteroaryl\/aryl)\u20103, 4\u2010dihydro\u20101\u2032 H, 2H\u2010[3, 4\u2032\u2010bipyrazole]\u20102\u2010carboxamides as EGFR kinase inhibitors: synthesis, anticancer evaluation, and molecular docking studies","volume":"353","author":"Nawaz","year":"2020","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2025.118276_b0130","first-page":"05144","article-title":"Synthesis, characterization, in silico, and in vitro biological screening of coordination compounds with 1, 2, 4-triazine based biocompatible ligands and selected 3d-metal ions","volume":"6","author":"Prasad","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.bmc.2025.118276_b0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejmech.2013.11.029","article-title":"Recent advances in small organic molecules as DNA intercalating agents: synthesis, activity, and modeling","volume":"74","author":"Rescifina","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118276_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400403","article-title":"Synthesis, in vitro anticancer activity, and pharmacokinetic profiling of the new tetrahydropyrimidines: Part I","volume":"357","author":"Milovi\u0107","year":"2024","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2025.118276_b0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mjafi.2019.12.001","article-title":"Metabolic syndrome: the Indian public health perspective","volume":"76","author":"Bhalwar","year":"2020","journal-title":"Med J Armed Forces India"},{"issue":"123364","key":"10.1016\/j.bmc.2025.118276_b0150","article-title":"Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modulation of miR-193b\/KRAS\/LAMC2\/ERK\/AKT signaling cascade","author":"Kirtonia","year":"2025","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2025.118276_b0155","first-page":"1937","article-title":"Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.bmc.2025.118276_b0160","doi-asserted-by":"crossref","first-page":"16428","DOI":"10.1039\/C7RA00425G","article-title":"The effect of incorporating carboxylic acid functionalities into 2, 2\u2032-bipyridine on the biological activity of the complexes formed: synthesis, structure, DNA\/protein interaction, antioxidant activity and cytotoxicity","volume":"7","author":"Kamatchi","year":"2017","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2025.118276_b0165","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1021\/cr0781059","article-title":"Square-planar Pd (II), Pt (II), and Au (III) terpyridine complexes: their syntheses, physical properties, supramolecular constructs, and biomedical activities","volume":"108","author":"Eryazici","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2025.118276_b0170","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1021\/om800212t","article-title":"Synthesis, characterization, and properties of luminescent organoiridium (III) polypyridine complexes appended with an alkyl chain and their interactions with lipid bilayers, surfactants, and living cells","volume":"27","author":"Lo","year":"2008","journal-title":"Organometallics"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:35:13Z","timestamp":1775097313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625002172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":34,"alternative-id":["S0968089625002172"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118276","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting MAP kinase for inhibiting Leishmania promastigotes and amastigotes stages by L-alanine derived molecules and their anticancer potential against PANC-1 cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118276"}}